SHAVERS CHERYL L
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Voyager Completes Griffin-1 Testing, TD Cowen Lowers Target. Voyager Technologies confirmed its Griffin-1 lunar lander passed acceptance testing, targeting a late 2026 launch. The company also secured a cancer research mission management contract and appointed a new investor relations lead. Meanwhile, TD Cowen maintained its positive stance but lowered its price target to $36, reflecting updated valuation metrics.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ITT Announces Q3 2026 Earnings Release; Conglomerates Lag Behind. ITT has set a date for its third‑quarter 2026 earnings release and conference call. Analysts are comparing ITT to MITSY to assess value, while a recent Yahoo piece notes that conglomerate stocks are trailing ITT this year. The company’s focus on expanding its flow business could strengthen its core operations.
Transaction History
| KN | ▼ Sell | Open Market | 6,443 | $253K | 8/17/2026 | View on chart |
| KN | ▼ Sell | Open Market | 175 | $7K | 8/17/2026 | View on chart |
| VOYG | ▲ Buy | Grant | 3,130 | $0 | 5/29/2026 | View on chart |
| KN | ▲ Buy | Grant | 6,265 | $190K | 4/28/2026 | View on chart |
| KN | ▼ Sell | Open Market | 3,700 | $101K | 2/20/2026 | View on chart |
| KN | ▼ Sell | Open Market | 21,047 | $421K | 8/5/2025 | View on chart |
| VOYG | ▲ Buy | Grant | 7,500 | $0 | 6/13/2025 | View on chart |
| KN | ▲ Buy | Grant | 11,890 | $190K | 4/29/2025 | View on chart |
| KN | ▼ Sell | Open Market | 12,579 | $217K | 9/23/2024 | View on chart |
| ITT | ▲ Buy | Grant | 1,114 | $0 | 5/15/2024 | View on chart |
| KN | ▲ Buy | Grant | 10,740 | $170K | 4/30/2024 | View on chart |
| KN | ▼ Sell | Open Market | 12,205 | $203K | 5/18/2023 | View on chart |
| ITT | ▲ Buy | Grant | 1,704 | $0 | 5/10/2023 | View on chart |
| KN | ▲ Buy | Grant | 10,373 | $170K | 5/2/2023 | View on chart |
| KN | ▼ Sell | Open Market | 3,100 | $58K | 5/23/2022 | View on chart |
| ITT | ▲ Buy | Grant | 1,999 | $0 | 5/18/2022 | View on chart |
| KN | ▲ Buy | Grant | 9,316 | $170K | 4/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Knowles faces mixed signals with insider sale and analyst caution
Knowles is in focus this week as it prepares to attend the Midwest IDEAS Conference, with discussion building around what counts as a fair value for the stock. At the same time, several analyst pieces are highlighting concerns about the company's risk profile, with one naming Knowles among Russell 2000 names to avoid and another suggesting investors look at a different stock instead. Adding to the picture, company Director Shavers sold $260,000 worth of stock. The stock is trading near the middle of its 52-week range, with a trailing P/E well above peers and an average analyst price target of $43.75.
Knowles faces mixed signals with insider sale and analyst caution. Knowles is in focus this week as it prepares to attend the Midwest IDEAS Conference, with discussion building around what counts as a fair value for the stock. At the same time, several analyst pieces are highlighting concerns about the company's risk profile, with one naming Knowles among Russell 2000 names to avoid and another suggesting investors look at a different stock instead. Adding to the picture, company Director Shavers sold $260,000 worth of stock. The stock is trading near the middle of its 52-week range, with a trailing P/E well above peers and an average analyst price target of $43.75.